Alignment Healthcare, Inc.
$14.25
+7.1%Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform. It provides customized health care in the United States to seniors and those who need it through its Medicare advantage plans. The company owns Medicare advantage plans in the states of California, North Carolina, and Nevada. It also coordinates and provides covered health care services, including professional, institutional, and ancillary services to members enrolled in certain benefit plans of unaffiliated Medicare Advantage Health Maintenance Organizations. The company was founded in 2013 and is based in Orange, California.
At a Glance
Live SnapshotIntrinsic Alpha Methodology
Thesis Lenses
Signal
Medium confidenceValuation multiple is compressed (P/E -3851.3).
Valuation inputs: P/E -3851.3, earnings yield N/A, momentum +7.1%.
If multiples stay elevated while momentum fades, downside repricing risk rises.
Driver
High confidenceReturn profile is soft (ROE -0.4%, ROIC +2.5%).
Profitability stack: net margin -0.0%, ROE -0.4%, ROIC +2.5%.
Quality deterioration often appears in margins before it shows up in headline EPS.
Risk
High confidenceDownside profile is elevated and scenario stress-testing is essential.
Risk factors: liabilities/assets +83.2%, momentum +7.1%, net margin -0.0%.
Higher leverage with weak momentum and thin margins can amplify drawdown severity.
Alignment Healthcare, Inc. Market vs Earnings Trajectory
Loading price and EPS data...
Alignment Healthcare, Inc. Fair Value Envelope
Alignment Healthcare, Inc. Profit Bridge
Profitability Analysis
Gross Margin
Thin margins leave little room for error. Cost management and pricing strategy are critical.
Operating Margin
Minimal operating profit suggests high operating costs or pricing challenges. Scalability is concerning.
Net Profit Margin
Net losses indicate the company is burning cash. Sustainability depends on path to profitability.
Profitability Insight
Non-operating losses: Core business is profitable but other expenses (interest, taxes, one-time items) are driving net losses. Review capital structure and non-operating items.
Alignment Healthcare, Inc. Cash Conversion Engine
Cash Flow Quality Analysis
FCF Conversion Rate
Negative free cash flow despite positive earnings raises concerns about cash generation ability or heavy capital requirements.
CapEx Intensity
Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.
FCF Growth Trend
Strong FCF growth demonstrates improving cash generation and business momentum. Positive signal for sustainability.
Working Capital Impact
Working capital inflow boosted cash flow. Efficient management of receivables, inventory, and payables contributing positively.
Alignment Healthcare, Inc. Funding & Solvency Profile
Financial Health Analysis
Current Ratio
Strong liquidity. The company has adequate resources to meet short-term liabilities.
Debt-to-Equity Ratio
High financial leverage. Heavy reliance on debt may indicate increased financial risk and potential solvency concerns.
Working Capital
Strong working capital position provides significant operational flexibility and financial cushion.
Asset Composition
Asset-light business model with high liquidity. Majority of assets are easily convertible to cash.
Alignment Healthcare, Inc. Street Expectations Map
Wall Street analysts project that ALHC stock may rise significantly over the coming 12 months. The consensus 1-year price target stands at 24.33, with estimates ranging from a low of 16.00 to a high of 30.00.
The consensus 1-year price target stands at 24.33, with estimates ranging from a low of 16.00 to a high of 30.00.
Analyst Consensus Analysis
Upside Potential
Substantial upside potential. Analysts see significant value gap, suggesting the stock may be materially undervalued at current levels.
Analyst Agreement
Mixed analyst views. Wide target range suggests differing opinions on key value drivers, growth prospects, or risk factors.
Analyst Conviction
Bearish or uncertain outlook. Limited upside or poor consensus suggests challenges ahead or fundamental concerns.
Market Sentiment Insight
High risk, high reward: Substantial upside potential exists, but wide analyst disagreement signals execution risk or unclear catalysts. Thorough due diligence essential before committing capital.
Alignment Healthcare, Inc. Insider Positioning
During the last 12 months, insiders have purchased $198K and sold $1.12B worth of ALHC shares, resulting in $1.12B of net selling activity.
3 Months
14.8K
197.63K
1.2M
22.85M
-22.7M
-$22.65M
3-6 Months
0
0.00
23.4M
437.52M
-437.5M
-$437.52M
6-9 Months
0
0.00
40.3M
645.22M
-645.2M
-$645.22M
9-12 Months
0
0.00
864.8K
12.59M
-12.6M
-$12.59M
Top Buyers
Kent Mark D.
Officer: President - Mso
$198K
Top Sellers
General Atlantic (Aln Hlth), L.P.
10 Percent Owner
$521.98M
General Atlantic, L.P.
10 Percent Owner
$521.98M
Kao John E
Director, Officer: Chief Executive Officer
$45.83M
Maroney Dawn Christine
Officer: President
$15.76M
Scavo Robert L.
Officer: Chief Information Officer
$3.14M
Insider Activity Analysis
Net Insider Sentiment
Strong bearish signal with $1.12B net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.
Buy/Sell Ratio
Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.
Recent Trend (3 Months)
Heavy recent selling activity. Recent insider sales notably exceed purchases—may warrant investigation into company developments.
Insider Participation
5 insider sellers vs. 1 buyers. Widespread selling across multiple insiders may signal concerns.
Insider Activity Insight
Multiple red flags: Heavy selling, numerous sellers, and continued recent selling create a concerning pattern. Investigate fundamental drivers and consider whether company guidance or industry conditions have deteriorated.
No Dividend Yield Data
ALHC has not reported any dividend yield values in the available annual periods.
alhc Dividend History
Learning Layer
Related Guides
Build conviction on ALHC by pairing this stock hub with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.